Literature DB >> 30260458

The Effect of Reducing the "Jumping to Conclusions" Bias on Treatment Decision-Making Capacity in Psychosis: A Randomized Controlled Trial With Mediation Analysis.

David T Turner1, Angus MacBeth2, Amanda Larkin3, Steffen Moritz4, Karen Livingstone5, Alison Campbell5, Paul Hutton6.   

Abstract

BACKGROUND: Evidence-based psychological interventions to support treatment decision-making capacity (capacity) in psychosis do not currently exist. This study sought to establish whether reducing the extent to which this group form conclusions based on limited evidence, also known as the "jumping-to-conclusions" (JTC) bias, could improve capacity.
METHODS: In a randomized controlled open trial, 37 patients aged 16-65 years diagnosed with schizophrenia-spectrum disorders were randomly assigned (1:1) to receive a single-session intervention designed to reduce the JTC bias (MCT-JTC; adapted from Metacognitive Training [MCT]) or an attention control (AC) condition designed to control for therapist attention, duration, modality, and face validity. Primary outcomes were treatment decision-making capacity measured by the MacArthur Competency Assessment Tool for Treatment (MacCAT-T) and the jumping-to-conclusions reasoning bias measured by draws to decision on the beads task, each of which were administered by the psychologist delivering the intervention.
RESULTS: Those receiving MCT-JTC had large improvements in overall capacity (d = 0.96, P < .05) and appreciation (d = 0.87, P < .05) compared to those receiving AC. Reduction in JTC mediated a large proportion of the effect of group allocation on understanding, appreciation, reasoning, and overall MacCAT-T scores.
CONCLUSION: This is the first experimental investigation of the effect of a psychological intervention on treatment decision-making capacity in psychosis. It provides early evidence that reducing the JTC bias is associated with large and rapid improvements in capacity. Due to limited resources, assessments were administered by the researchers delivering the intervention. Results should therefore be considered preliminary and a larger, definitive trial addressing methodological limitations is warranted.
© The Author(s) 2018. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  RCT; capacity; jumping-to-conclusions; metacognitive therapy; psychosis

Year:  2019        PMID: 30260458      PMCID: PMC6581146          DOI: 10.1093/schbul/sby136

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  35 in total

1.  Mediation analysis.

Authors:  David P MacKinnon; Amanda J Fairchild; Matthew S Fritz
Journal:  Annu Rev Psychol       Date:  2007       Impact factor: 24.137

2.  A simple sample size formula for analysis of covariance in randomized clinical trials.

Authors:  George F Borm; Jaap Fransen; Wim A J G Lemmens
Journal:  J Clin Epidemiol       Date:  2007-06-06       Impact factor: 6.437

3.  Cognitive Biases Questionnaire for psychosis.

Authors:  Emmanuelle R Peters; Steffen Moritz; Matthias Schwannauer; Zoe Wiseman; Kathryn E Greenwood; Jan Scott; Aaron T Beck; Catherine Donaldson; Roger Hagen; Kerry Ross; Ruth Veckenstedt; Rebecca Ison; Sally Williams; Elizabeth Kuipers; Philippa A Garety
Journal:  Schizophr Bull       Date:  2013-02-14       Impact factor: 9.306

4.  Probabilistic judgements in deluded and non-deluded subjects.

Authors:  S F Huq; P A Garety; D R Hemsley
Journal:  Q J Exp Psychol A       Date:  1988-11

5.  Metacognitive training for patients with schizophrenia: preliminary evidence for a targeted, single-module programme.

Authors:  Ryan P Balzan; Paul H Delfabbro; Cherrie A Galletly; Todd S Woodward
Journal:  Aust N Z J Psychiatry       Date:  2013-10-24       Impact factor: 5.744

6.  Including all individuals is not enough: lessons for intention-to-treat analysis.

Authors:  Ian R White; James Carpenter; Nicholas J Horton
Journal:  Clin Trials       Date:  2012-07-02       Impact factor: 2.486

7.  Psychiatrists' use of shared decision making in the treatment of schizophrenia: patient characteristics and decision topics.

Authors:  Johannes Hamann; Rosmarie Mendel; Rudolf Cohen; Stephan Heres; Matthias Ziegler; Markus Bühner; Werner Kissling
Journal:  Psychiatr Serv       Date:  2009-08       Impact factor: 3.084

8.  Individualized metacognitive therapy program for patients with psychosis (MCT+): introduction of a novel approach for psychotic symptoms.

Authors:  Francesca Bohn Vitzthum; Ruth Veckenstedt; Steffen Moritz
Journal:  Behav Cogn Psychother       Date:  2013-05-01

9.  Effects of group metacognitive training (MCT) on mental capacity and functioning in patients with psychosis in a secure forensic psychiatric hospital: a prospective-cohort waiting list controlled study.

Authors:  Marie Naughton; Andrea Nulty; Zareena Abidin; Mary Davoren; Sarah O'Dwyer; Harry G Kennedy
Journal:  BMC Res Notes       Date:  2012-06-18

10.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18
View more
  2 in total

1.  Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia: A Randomized Controlled Trial.

Authors:  Mei-Chi Hsu; Wen-Chen Ouyang
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

2.  Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis.

Authors:  Ana Catalan; Stefania Tognin; Matthew J Kempton; Daniel Stahl; Gonzalo Salazar de Pablo; Barnaby Nelson; Christos Pantelis; Anita Riecher-Rössler; Rodrigo Bressan; Neus Barrantes-Vidal; Marie-Odile Krebs; Merete Nordentoft; Stephan Ruhrmann; Gabriele Sachs; Bart P F Rutten; Jim van Os; Lieuwe de Haan; Mark van der Gaag; Lucia R Valmaggia; Philip McGuire
Journal:  Psychol Med       Date:  2020-10-06       Impact factor: 10.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.